| Literature DB >> 29500254 |
Beibei Liang1,2, Adam P Roberts3,4, Xuebin Xu5, Chaojie Yang2, Xiaoxia Yang2, Jinyan Wang2, Shengjie Yi6, Yongrui Li2, Qiuxia Ma2, Fuli Wu2, Shaofu Qiu7,2, Hongbin Song7,2.
Abstract
Since the initial discovery of mcr-1 in an Escherichia coli isolate from China, the gene has also been detected in Klebsiella pneumoniae and Salmonella enterica but is rarely reported in other Enterobacteriaceae Here, we report the isolation and identification of a Shigella flexneri strain harboring mcr-1 from stool samples in a pig farm in China from 2009. The MIC of colistin for the isolate is 4 μg/ml. Conjugation assays showed that the donor S. flexneri strain has functional and transferable colistin resistance. Sequencing revealed that mcr-1 was present on a putative composite transposon flanked by inverted repeats of ISApl1IMPORTANCE There are four species of Shigella, and Shigella flexneri is the most frequently isolated species in low- and middle-income countries (LMICs). In this study, we report a functional, transferable, plasmid-mediated mcr-1 gene in S. flexneri We have shown that mcr-1 is located on a novel composite transposon which is flanked by inverted repeats of ISApl1 The host strain is multidrug resistant, and this multidrug resistance is also transferable. The finding of a functional mcr-1 gene in S. flexneri, a human-associated Enterobacteriaceae family member, is a cause for concern as infections due to S. flexneri are the main Shigella infections in most low- and middle-income countries.Entities:
Keywords: ISApl1; Tn6390; composite transposon; multidrug resistance; plasmid transfer
Mesh:
Substances:
Year: 2018 PMID: 29500254 PMCID: PMC5881045 DOI: 10.1128/AEM.02655-17
Source DB: PubMed Journal: Appl Environ Microbiol ISSN: 0099-2240 Impact factor: 4.792
Antimicrobial susceptibility results of S. flexneri C960, E. coli J53, and a transconjugant
| Drug | MIC (μg/ml) for the strain | ||
|---|---|---|---|
| C960 | J53 | Transconjugant | |
| Colistin | ≤0.2 | ||
| Polymyxin B | ≤0.2 | ||
| Tetracycline | ≤4 | ||
| Ticarcillin | ≤16 | ||
| Ampicillin | ≤8 | ||
| Trimethoprim-sulfamethoxazole | ≤2 | ||
| Sulfafurazole | ≤16 | ||
| Streptomycin | ≤2 | ||
| Cefazolin | ≤8 | ≤8 | ≤8 |
| Cefoxitin | ≤8 | ≤8 | ≤8 |
| Ceftazidime | ≤1 | ≤1 | ≤1 |
| Ceftriaxone | ≤1 | ≤1 | ≤1 |
| Cefoperazone | ≤16 | ≤16 | ≤16 |
| Ceftiofur | ≤0.12 | ≤0.5 | ≤0.5 |
| Cefepime | ≤8 | ≤8 | ≤8 |
| Piperacillin | ≤16 | ≤16 | ≤16 |
| Amoxicillin-clavulanic acid | ≤4 | ≤4 | ≤8 |
| Ticarcillin-clavulanic acid | ≤16 | ≤16 | ≤16 |
| Aztreonam | ≤1 | ≤1 | ≤1 |
| Imipenem | ≤4 | ≤4 | ≤4 |
| Nalidixic acid | ≤4 | ≤4 | ≤8 |
| Ciprofloxacin | ≤0.25 | ≤0.015 | ≤0.5 |
| Norfloxacin | ≤4 | ≤4 | ≤4 |
| Levofloxacin | ≤2 | ≤2 | ≤2 |
| Tobramycin | ≤4 | ≤4 | ≤4 |
| Gentamicin | ≤4 | ≤4 | ≤4 |
| Amikacin | ≤16 | ≤16 | ≤16 |
| Chloramphenicol | ≤8 | ≤8 | ≤8 |
| Nitrofurantoin | ≤32 | ≤32 | ≤32 |
| Azithromycin | ≤2 | ≤4 | ≤4 |
Values in boldface indicate resistance; all other values indicate susceptibility.
FIG 1Structure of plasmid pRC960-2 carrying mcr-1 from Shigella flexneri strain C960. Genes are denoted by arrows and colored based on gene function classification. The innermost circle represents GC content. The second circle presents GC-skew [(G − C)/(G + C)].
FIG 2Comparison of the surrounding structure of mcr-1 in four similar plasmids: pHNSHP45, pABC149-MCR-1, pEG430-1, and pRC960-2. Compared with the sequences of the other three plasmids, an additional, inverted repeat of ISApl1 is present downstream of mcr-1 in plasmid pRC960-2. A single SNP upstream of mcr-1 (−36) changes from T to C in plasmid pRC960-2.
FIG 3Comparison of the circular genome maps of plasmid sequences of three plasmid genome structures with pHNSHP45 sequence as a reference genome. The green circles represent, from inside to outside, pRC960-2, pEG430-1, pABC149-MCR-1, and pHNSHP45 plasmid sequences, respectively, with respect to the reference pHNSHP45 plasmid genome. In pRC960-2, there is an inverted copy of ISApl1 flanking mcr-1. A 22-bp duplication of bases 503 to 524 of the mcr-1 ORF is found in plasmid pEG430-1. The single SNPs upstream of mcr-1 in pRC960-2, pABC149-MCR-1, and pEG430-1 are the same.
FIG 4(A) The linear structure of genes surrounding mcr-1. The small arrows indicate the locations of the primers used to detect the circular structure. (B) The presumed structure of plasmid pRC960-2 of S. flexneri strain C960. (C) The sequencing result of the PCR products generated by primers IS-2 and IS-6; the fragment amplified by this pair of primers is 1,293 bp and consists of a part of nikB and a complete ISApl1. (D) Gel picture of the 1,293-bp PCR products generated by primers IS-2 and IS-6 targeting sequences surrounding Tn6390. The amplicon of this pair of primers consists of a part of nikB and a complete ISApl1. (E) Schematic representation of the presumed circular structure including mcr-1.
Primers used in PCR amplification of antibiotic resistance genes
| Primer target group and name | Nucleotide sequence (5′ to 3′) | Target | Length (bp) | Reference |
|---|---|---|---|---|
| Beta-lactamases | ||||
| blaCTX-M-1 group-F | GGTTAAAAAATCACTGCGTC | 873 | This study | |
| blaCTX-M-1 group-R | TTACAAACCGTCGGTGACGA | 873 | This study | |
| blaCTX-M-9 group-F | AGAGTGCAACGGATGATG | 868 | This study | |
| blaCTX-M-9 group-R | CCAGTTACAGCCCTTCGG | 868 | This study | |
| blaCTX-M-2/8/25 group-F | ACCGAGCCSACGCTCAA | 221 | This study | |
| blaCTX-M-2/8/25 group-R | CCGCTGCCGGTTTTATC | 221 | This study | |
| blaTEM-F | ATGAGTATTCAACATTTCCG | 1,080 | ||
| blaTEM-R | CCAATGCTTAATCAGTGAGG | 1,080 | ||
| blaOXA-F | ATTAAGCCCTTTACCAAACCA | 890 | ||
| blaOXA-R | AAGGGTTGGGCGATTTTGCCA | 890 | ||
| blaVIM-F3 | AGTGGTGAGTATCCGACAG | 509 | ||
| blaVIM-R3 | ATGAAAGTGCGTGGAGAC | 509 | ||
| blaNDM-1-F | GTCTGGCAGCACACTTCCTA | 515 | This study | |
| blaNDM-1-R | TAGTGCTCAGTGTCGGCATC | 515 | This study | |
| Integrons | ||||
| IntI1-F2 | ACATGTGATGGCGACGCACGA | 569 | ||
| IntI1-R2 | ATTTCTGTCCTGGCTGGCGA | 569 | ||
| IntI2-F3 | CACGGATATGCGACAAAAAGGT | 789 | ||
| IntI2-R3 | GTAGCAAACGAGTGACGAAATG | 789 | ||
| hep58 | TCATGGCTTGTTATGACTGT | Class 1 integron variable region | Variable | This study |
| hep59 | GTAGGGCTTATTATGCACGC | Class 1 integron variable region | Variable | This study |
| hep74 | CGGGATCCCGGACGGCATGCACGATTTGTA | Class 2 integron variable region | Variable | |
| hep51 | GATGCCATCGCAAGTACGAG | Class 2 integron variable region | Variable | |
| Chromosomal mutation-mediated quinolone resistance | ||||
| gyrA-F | TACACCGGTCAACATTGAGG | 648 | ||
| gyrA-R | TTAATGATTGCCGCCGTCGG | 648 | ||
| gyrB-F | TGAAATGACCCGCCGTAAAGG | 309 | ||
| gyrB-R | GCTGTGATAACGCAGTTTGTCCGGG | 309 | ||
| parC-F | GTACGTGATCATGGACCGTG | 531 | ||
| parC-R | TTCGGCTGGTCGATTAATGC | 531 | ||
| parE-F | ATGCGTGCGGCTAAAAAAGTG | 290 | ||
| parE-R | TCGTCGCTGTCAGGATCGATAC | 290 | ||
| Plasmid-mediated quinolone resistance | ||||
| qnrA-F3 | ATTTCTCACGCCAGGATTTG | 516 | ||
| qnrA-R3 | GATCGGCAAAGGTYAGGTCA | 516 | ||
| qnrB-F | GATCGTGAAAGCCAGAAAGG | 469 | ||
| qnrB-R | ACGAYGCCTGGTAGTTGTCC | 469 | ||
| qnrD-F | CGAGATCAATTTACGGGGAATA | 656 | ||
| qnrD-R | AACAAGCTGAAGCGCCTG | 656 | ||
| qnrS-F | ACGACATTCGTCAACTGCAA | 417 | ||
| qnrS-R | TAAATTGGCACCCTGTAGGC | 417 | ||
| aac(6′)-Ib-cr-F | GCAACGCAAAAACAAAGTTAGG | 560 | ||
| aac(6′)-Ib-cr-R | GTGTTTGAACCATGTACA | 560 |
Primers used in PCR amplification to confirm the arrangement of the transposon ISApl1-mcr-1-orf-ISApl1
| Primer name | Nucleotide sequence (5′ to 3′) | Target or function | Length (bp) | Reference |
|---|---|---|---|---|
| IS-1 | TACTTCCTACCGCCATCTTACA | The whole length of Tn | 4,537 | This study |
| IS-4 | TACTTCCTACCGACATCTTAC | The whole length of Tn | 4,537 | This study |
| MCR1-RC-F | CTTGGTCGGTCTGTAGGG | To test the ability of Tn | 1,598 | |
| MCR1-R | TGTCCACGGTTGATGCG | To test the ability of Tn | 1,598 | |
| IS-5 | TCTGTTTGGGGTTGATT | IS | 1,904 | This study |
| IS-7 | AAAGTCAAAGACCGCACC | IS | 1,904 | This study |
| IS-2 | GAGCCATACGGTGGTGT | The intact IS | 1,293 | This study |
| IS-6 | CGAATCCGATTTGCTTA | The intact IS | 1,293 | This study |
| IS-8 | CACAAGAACAAACGGACTGAC | IS | This study | |
| IS-a | AACGCCTACTGGCTGAGATGAG | To sequence Tn | This study | |
| IS-b | GGTCGCAACCAGCAAG | To sequence Tn | This study | |
| IS-c | GTGGCGTTCAGCAGTCATT | To sequence Tn | This study | |
| IS-d | GCTTACCCACCGAGTAGATT | To sequence Tn | This study | |
| IS-e | TGGTCGCTGATTGGTTTT | To sequence Tn | This study | |
| IS-f | GACACCACCGTATGGCTCA | To sequence Tn | This study |